Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundMRSA and PRSP resistance has surged over 30 years, threatening clinical outcomes; China-developed cefathiamidine sodium, with enhanced pharmacokinetics, offers potent activity against these Gram-positive pathogens.PurposeThis study evaluates the …